The Associations Between Gut Length, Gut Microbiota and Food Assimilation
NCT ID: NCT06377956
Last Updated: 2026-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2024-05-15
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut Microbiota and Stool Frequency
NCT03153059
Characterization of the Gut Microbiota Composition and Activity After Three Weeks of Chitin-glucan Supplementation
NCT03505177
Probiotic Intervention for Gut Function
NCT05155449
Nutrition, Gut Microbiota and Health : Feces Sample Collection in NutriNet-Santé Participants
NCT06941090
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The gut will be scanned using Magnetic Resonance Imaging (MRI) to calculate gut length. To obtain clearer images, volunteers will be asked to drink 1/1.5 sachet of He Shuang (polyethylene glycol electrolyte powder, molecular weight of 4000) and injected Raceanisodamine Hydrochloride Injection with 10 mg by intramuscular. Volunteers will be asked to drink He Shuang, which dissolved in 1/1.5L of water for the purpose of filling the intestines. As a contrast to improve imaging during scanning.
Volunteers will be given the experimental meal, which providing enough energy for volunteers to eat as much as they want. Feces and urine will be collected to calculate the assimilation rate. To more accurately label the food, edible polyethylene glycol with a molecular weight of 3350(PEG3350) is used. Provides 1.5g of PEG3350 per day, to be used with meals. PEG3350 reaches a steady state in the intestinal tract for 3 days. Food will be provided for seven days during the test period, the first three days are aimed at stabilizing the PEG3350 in the intestine, and the samples to be counted are mainly collected in the last four days. Food assimilation rate and metabolizable energy will be calculated for the 4-day.
The gut microbiota will be analyzed by metagenomics and metabolomics. This study combines metabolomics analysis techniques with imaging and physiological measurements to focus on the potential relationship between gut length and food absorption rates. Researchers anticipate recruiting up to 100 healthy volunteers (body mass index ≥ 18.5).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Age between 18-40 years old, 100subjects(50 female and 50 man)
He Shuang(Polyethylene Glycol Electrolytes Powder):1/1.5 sachets of PEG(68.56-102.84g dissolved in water with1/1.5L ) were provided to volunteers based on body weight(BW): BW\<60 kg, 1 sachet , BW≥60 kg, 1.5 sachets, drinking an average of 200/250 mL every 15 minutes. It will cause frequent bowel motions or diarrhoea for a couple of hours afterwards.
Raceanisodamine Hydrochloride Injection: intramuscular injection of Raceanisodamine Hydrochloride Injection with 10mg. It may cause dry mouth, red face and blurred vision. The half-life of the medicine is 40 minutes and most of the above symptoms disappear within 1 to 3 hours.
Observation without intervention
Observation of gut length, food intake, fecal and urine calories, body composition, microbiota, metabolic rate, metabolomics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation without intervention
Observation of gut length, food intake, fecal and urine calories, body composition, microbiota, metabolic rate, metabolomics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular bowel movements.
Exclusion Criteria
* Individuals with mental illnesses such as depression and claustrophobia;
* Individuals with glaucoma and prostate hypertrophy;
* Metal implants in the body;
* Pregnant and lactating women;
* Individuals with blood phobia, pathologic hypotension or hypertension;
* Use of antibiotics, probiotics, oral laxatives within 8 weeks;
* Individuals with metabolic diseases (e.g., chronic diseases such as diabetes mellitus); recent weight loss due to various medical reasons;
* Individuals with infectious diseases (e.g. HIV);
* Irregular diet, lifestyle, addiction to tobacco, alcohol or drugs.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John R. Speakman
Professor, chief researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John R Speakman, PhD
Role: STUDY_CHAIR
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen Institute of Advanced Technology
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIAT-IRB-240415-H0717
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.